Best in Biotech 4 Jul 2025 14 biotech companies to know in the Boston area in 2025 …DNA repair and cancer survival but have historically been very difficult to target with drugs. Their lead candidate, MOMA‑313, is a highly selective oral inhibitor of DNA polymerase theta, an… July 4, 2025 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Sponsored by Quantoom Biosciences 4 May 2023 How is Quantoom Biosciences’ Ntensify™ technology changing mRNA production? …Quantoom has addressed this need by providing its customers who acquire Ntensify with a DNA on-demand service. This service includes plasmid DNA engineering and amplification parameters screening, resulting in purified… May 4, 2023 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Apr 2025 Seven biotechs to watch in the hepatitis B space …These proteins are then imported into the nucleus of cells, where they bind to the cccDNA and the integrated HBV DNA. It cut both strands of DNA to inactivate them,… April 22, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2022 ABL and RD-Biotech to partner on cell and gene therapy manufacturing …development and production of plasmid DNA, monoclonal antibodies and recombinant proteins. This collaboration brings together RD-Biotech’s plasmid DNA (pDNA) GMP manufacturing services with ABL’s viral vector GMP manufacturing. As pDNA… October 26, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 8 Dec 2016 UPDATE: No Clear Winner in the CRISPR Patent Battle …but Doudna claims that this extension is obvious to any genome engineer. From left to right: Jennifer Doudna, Emmanuelle Charpentier and Feng Zhang This ongoing battle is not inexpensive: UC… December 8, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jan 2019 Huntington’s Could Be Diagnosed in Five Minutes With This Lab-on-a-Chip …sensitive than available techniques. “It is more sensitive because the microfluidics can concentrate the DNA in addition to separating it,” he explained. “So small amounts of DNA can be concentrated,… January 15, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 10 Oct 2016 The CRISPR Revolution is here, but how can we make it Useful? …work, cutting both strands of the DNA, implanting new DNA, and stitching it back together. Cas9 can also be modified with the addition of a protein to activate or repress… October 10, 2016 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Jun 2023 Six molecular diagnostics companies to watch …hematocrit. From the plasma that contains the cell-free DNA, a DNA library is created for sequencing. Data is then analyzed using next-generation sequencing of the DNA library, and utilizing bioinformatics,… June 15, 2023 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 11 Aug 2022 Biosecurity is synthetic biology’s most crucial ally …their own DNA, circumventing any quality controls. “We are working on an active solution to [DNA] screening that would allow shorter pieces of DNA to be screened routinely,” said Emily… August 11, 2022 - 6 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email
News and Trends 17 Nov 2022 New mitochondria study could pave way for disease treatments …amount of genetic information, mitochondrial DNA (mtDNA). The mtDNA, organized into dot-like structures called nucleoids, also moves around inside the mitochondria. The method of distribution of mtDNA remained unclear. Now… November 17, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 19 Sep 2024 Mitochondrial disease treatments: is a breakthrough on the horizon? …the mitochondria is an integral part of the immune system. Mitochondria contain circular DNA, and when this DNA leaves the cell, it is recognized as a danger signal by the… September 19, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 13 Mar 2025 Nine biotechs thriving in Seattle in 2025 …its candidate came to light. Its investigational drug is being tested to treat hepatitis B (HBV) infections. TUNE-401 utilizes Tune’s epigenetics platform TEMPO to epigenetically silence viral HBV DNA in… March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email